NDC 51808-208
Sestamibi
Sestamibi
Sestamibi is a Intravenous Injection, Powder, Lyophilized, For Solution in the Human Prescription Drug category. It is labeled and distributed by Anazaohealth Corporation. The primary component is Tetrakis(2-methoxyisobutylisocyanide)copper(i) Tetrafluoroborate.
| Product ID | 51808-208_118e6927-25b5-4bcc-8716-fcb5dbdc487b |
| NDC | 51808-208 |
| Product Type | Human Prescription Drug |
| Proprietary Name | Sestamibi |
| Generic Name | Sestamibi |
| Dosage Form | Injection, Powder, Lyophilized, For Solution |
| Route of Administration | INTRAVENOUS |
| Marketing Start Date | 2012-05-23 |
| Marketing Category | UNAPPROVED DRUG OTHER / UNAPPROVED DRUG OTHER |
| Labeler Name | AnazaoHealth Corporation |
| Substance Name | TETRAKIS(2-METHOXYISOBUTYLISOCYANIDE)COPPER(I) TETRAFLUOROBORATE |
| Active Ingredient Strength | 2 mg/1 |
| NDC Exclude Flag | E |
| Listing Certified Through | 2017-12-31 |